Neurobiological Basis of Response to Vyvanse in Adults with ADHD: An fMRI Study of Brain Activation

ID Number 09-1186

Principal Investigator(s)
Jeffrey Newcorn

Department(s) or Division(s)


The purpose of this study is to examine response to a commonly prescribed medication that is FDA approved for treatment of ADHD in adults. The study will include weekly visits with study physicians, evaluations for ADHD and other disorders, and medication for the treatment of ADHD.

Contact Information
Beth Krone
(212) 241-8012

Recruiting Patients: No